300+ investors in your industry, stage, and region Get
Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Retail
Film
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Software
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Real Estate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Sporting Goods
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Music
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Art
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Burkina Faso
Africa
LATAM
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Bangladesh
Spain
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Bolivia
Jersey
Estonia
Belize
Belarus
Finland
Italy
Algeria
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
Checkmate Capital, VC Fund

Checkmate Capital

VC Fund

Pasadena, United States

Checkmate Capital is a VC fund in Pasadena focused on Biotechnology and Health Care. The diverse experience of the Checkmate Capital team allows us to invest confidently across a range of industries including bio tech, ag tech, waste and energy.

Total investments:
10
Last investment:
Lead investor:
90%

Last updated:

Industries Checkmate Capital invests in

BiotechnologyHealth CareMedical DevicePharmaceuticalMedical

Stages Checkmate Capital invests in

SeedSeries APre-SeedSeries BConvertible Note

Countries Checkmate Capital invests in

United StatesSouth Korea

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Investment Focus

Industry

  • Biotechnology 7 (70%)
  • Health Care 2 (20%)
  • Medical Device 2 (20%)
  • Pharmaceutical 2 (20%)
  • Medical 1 (10%)
See all 11 industries →

Stage

  • Seed 4 (40%)
  • Series A 2 (20%)
  • Pre-Seed 1 (10%)
  • Series B 1 (10%)
  • Convertible Note 1 (10%)
See all 6 stages →

Country

  • United States 8 (80%)
  • South Korea 1 (10%)

Team

NameTitleInvestmentsLinksEmail
Scott Shaw
Scott Shaw Managing Director & Partner
Managing Director & Partner Total investments: 0
Find email
Tom Paschall
Tom Paschall Chief Executive Officer
Chief Executive Officer Total investments: 1
Find email

Investments

CompanyDescriptionRoundLinks
NeuroSigma NeuroSigma
NeuroSigma, Inc. is a medical device company based in Westwood, California. NeuroSigma is focused on commercialization of its unique Trigeminal Nerve Stimulation (TNS) technology, and has a growing pipeline of treatments targeting epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD).NeuroSigma is actively engaged in cutting-edge preclinical research and development, as well as groundbreaking Phase I, II, & III clinical trials. $1M / Venture - Series Unknown / Dec 15, 2025
Bredis Bredis
Bredis is a technology company that provides medical device technology commercialization, research, and development. Seed / May 19, 2023
Lynx Biosciences Lynx Biosciences
LynxBiosciencesis a clinical-stage biotechnology company focused on transforming the development of blood cancer therapies and delivering precise patient management by identifying the most promising therapeutic options. It is combining physiologically relevant suspension cell co-culture assays, automated microfluidics, and deep learning analyticswith the goal of rapidly advancing drug candidates in oncology and bringing personalized cancer treatments to patients. Seed / Nov 03, 2021
MAIA Biotechnology MAIA Biotechnology
MAIA Biotechnology is an immuno-oncology company that focuses on developing first-in-class drugs with novel mechanisms. $8M / Convertible Note / May 19, 2021
Elucid Elucid
Based in the Boston biotech and medtech hub, Elucid is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, ElucidVivo, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from asingle CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services. $10M / Series A / May 10, 2021
Lactiga Lactiga
Lactiga is an award-winning, venture-backed biotherapeutics company developing novel biologics to treat and prevent infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. We are unlocking the full therapeutic value of human milk to battle even the world’s most dangerous pathogens. $1.4M / Seed / Dec 01, 2020
Lactiga Lactiga
Lactiga is an award-winning, venture-backed biotherapeutics company developing novel biologics to treat and prevent infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. We are unlocking the full therapeutic value of human milk to battle even the world’s most dangerous pathogens. $1.4M / Pre-Seed / Dec 01, 2020
Monarch Biosciences Monarch Biosciences
MonarchBio is a Los Angeles-based biotechnology company focused on local delivery of cell therapies for treating solid tumors. MonarchBio's unique thin-film bio $1M / Seed / Apr 08, 2020
SiteFuel SiteFuel
SiteFuel team committed to a pretty high bar and they have not let us down. They needed a solution where they could make a single phone call have someone else manage the process for us. They have dozens of jobsites with their specialty equipment onsite and these need to stay up and running. SiteFuel has been able to get us fuel on-time, where theyneed it, using several suppliers, and without missing a beat. Great job They have thousands of units nationwide and the nature of the technology means that they cannot be without fuel to power their sites. SiteFuel has delivered for us time and time again, even in hard to reach places. They call them and they connect the dots $5M / Series A / Apr 25, 2018
TELA Bio TELA Bio
TELA Bio is a life science company that specializes in soft tissue reconstruction. The company aims to commercialize a portfolio of products that are purposefully designed to address a range of unmet needs in soft tissue repair. Series B / Apr 16, 2018

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
EdTech
Venture Capital
Video Games
Hospitality
Restaurants
Crowdfunding
Financial Services
Photography
Cryptocurrency
Digital Media
Big Data
Email
Artificial Intelligence
Clean Energy
Non Profit
Social Impact
Energy
SaaS
Google
CleanTech
Consumer
Health Care
Enterprise Software
Local
Travel
Platforms
InsurTech
Construction
Mobile
Oil and Gas
Retail
Film
Payments
Organic Food
Marketplace
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Medical Device
Wellness
Education
Sports
Legal
Automotive
eSports
Biotechnology
Renewable Energy
Facebook
Software
Blockchain
Theatre
Medical
Web3
Recruiting
Beauty
Fashion
Infrastructure
Social
Celebrity
Cannabis
LGBT
Climate
Real Estate
Food and Beverage
Life Science
Publishing
Wine and Spirits
Mobile Apps
Sporting Goods
Finance
Manufacturing
FinTech
Social Media
Franchise
Internet
Music
Mobile Advertising
Android
Impact
Proptech
Hardware
Transportation
Biotech
Sustainability
Enterprise
Community
Media (Entertainment)
Art
Any country
Afghanistan
Greece
Thailand
United Arab Emirates
Andorra
Dominica
Japan
Brazil
Singapore
Egypt
United Kingdom
Oceania
Argentina
Tunisia
Taiwan
Zimbabwe
Faroe Islands
South Korea
Hong Kong
Benin
Nigeria
Togo
Croatia
Gibraltar
Guinea
Kyrgyzstan
Norway
Haiti
Sudan
Malawi
Isle of Man
Iran
Madagascar
Lesotho
Russian Federation
Turkey
Liberia
Nepal
Pakistan
Mexico
Tajikistan
Sweden
Zambia
Romania
Burkina Faso
Africa
LATAM
Oman
Poland
Puerto Rico
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Côte d'Ivoire
Czech Republic
Kuwait
Marshall Islands
Luxembourg
Malta
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
Morocco
New Zealand
Jamaica
Sri Lanka
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Venezuela
Myanmar
Uganda
Uruguay
Moldova
Botswana
Seychelles
Paraguay
South Africa
France
Denmark
Georgia
Ghana
Iraq
Philippines
Portugal
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Indonesia
Middle East
Dominican Republic
Asia
Bermuda
Albania
Bangladesh
Spain
Angola
Europe
Cyprus
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Bahamas
Bahrain
Bolivia
Jersey
Estonia
Belize
Belarus
Finland
Italy
Algeria
Hungary
Grenada
Israel
Honduras
Lithuania
Cambodia
Iceland
Liechtenstein
Lebanon
Peru
Mongolia
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does Checkmate Capital invest in?

Checkmate Capital invests primarily in Biotechnology, Health Care and Medical Device startups, most often at Seed and Series A stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

How do I contact Checkmate Capital?

Public channels for Checkmate Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at Checkmate Capital?

The team at Checkmate Capital includes Scott Shaw (Managing Director & Partner) and Tom Paschall (Chief Executive Officer). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
Checkmate Capital Checkmate Capital Find emails